BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu WF, Zhang Q, Ding CJ, Sun HY, Che Y, Huang H, Wang Y, Wu JW, Hao HP, Cao LJ. Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure. Acta Pharmacol Sin 2021;42:68-76. [PMID: 32457417 DOI: 10.1038/s41401-020-0434-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shojaie L, Iorga A, Dara L. Cell Death in Liver Diseases: A Review. Int J Mol Sci 2020;21:E9682. [PMID: 33353156 DOI: 10.3390/ijms21249682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
2 Yang F, Bettadapura SN, Smeltzer MS, Zhu H, Wang S. Pyroptosis and pyroptosis-inducing cancer drugs. Acta Pharmacol Sin 2022. [PMID: 35288674 DOI: 10.1038/s41401-022-00887-6] [Reference Citation Analysis]
3 Wang J, Ye T, Wang S, Wang J, Jin Y. Molecular mechanisms and therapeutic relevance of gasdermin E in human diseases. Cell Signal 2021;90:110189. [PMID: 34774988 DOI: 10.1016/j.cellsig.2021.110189] [Reference Citation Analysis]
4 Shen X, Wang H, Weng C, Jiang H, Chen J. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis 2021;12:186. [PMID: 33589596 DOI: 10.1038/s41419-021-03458-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
5 Li W, Sun J, Zhou X, Lu Y, Cui W, Miao L. Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy. Front Pharmacol 2021;12:780790. [PMID: 34867412 DOI: 10.3389/fphar.2021.780790] [Reference Citation Analysis]
6 Li T, Zheng G, Li B, Tang L. Pyroptosis: A promising therapeutic target for noninfectious diseases. Cell Prolif 2021;54:e13137. [PMID: 34590363 DOI: 10.1111/cpr.13137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lin J, Hu P, Wang Y, Tan Y, Yu K, Liao K, Wu Q, Li T, Meng Q, Lin J, Liu Z, Pu H, Ju H, Xu R, Qiu M. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-00889-0] [Reference Citation Analysis]
8 Xia Y, Jin Y, Cui D, Wu X, Song C, Jin W, Huang H. Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis. Front Pharmacol 2022;13:860546. [DOI: 10.3389/fphar.2022.860546] [Reference Citation Analysis]
9 Liao X, Dai Y, Zhao Y, Nie K. Gasdermin E: A Prospective Target for Therapy of Diseases. Front Pharmacol 2022;13:855828. [DOI: 10.3389/fphar.2022.855828] [Reference Citation Analysis]